Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6–8 months after the infection
2021 · Med · 196 citations
https://doi.org/10.1016/j.medj.2021.02.001
L
Likun Du
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
85
Papers
4.1K
Citations
37
h-index
53
i10-index
Likun Du is an academic researcher from Heilongjiang University of Chinese Medicine. The author has contributed to research in topics: Immunodeficiency and Autoimmune Disorders & SARS-CoV-2 and COVID-19 Research & DNA Repair Mechanisms. The author has an h-index of 37, co-authored 73 publications.
ORCID: 0000-0002-8448-2187Papers by this author
worksHeterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant
2022 · Nature Communications · 161 citations
https://doi.org/10.1038/s41467-022-30340-5
<i>EXTL3</i> mutations cause skeletal dysplasia, immune deficiency, and developmental delay
2017 · The Journal of Experimental Medicine · 83 citations
https://doi.org/10.1084/jem.20161525
SARS-CoV-2–specific B- and T-cell immunity in a population-based study of young Swedish adults
2021 · Journal of Allergy and Clinical Immunology · 56 citations
https://doi.org/10.1016/j.jaci.2021.10.014
Screening of functional and positional candidate genes in families with common variable immunodeficiency
2008 · BMC Immunology · 37 citations
https://doi.org/10.1186/1471-2172-9-3
Tumor evolution and immune microenvironment dynamics in primary and relapsed mantle cell lymphoma
2025 · Cell Reports Medicine · 4 citations
https://doi.org/10.1016/j.xcrm.2025.102318
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat